Article
Dihydropyridine receptor mutations cause hypokalemic periodic paralysis.
Cell - 17 Jun 1994
Ptácek L J, Tawil R, Griggs R C, Engel A G, Layzer R B, Kwieciński H, McManis P G, Santiago L, Moore M, Fouad G
Abstract excerpt
Hypokalemic periodic paralysis (hypoKPP) is an autosomal dominant skeletal muscle disorder manifested by episodic weakness associated with low serum potassium. Genetic linkage analysis has localized the hypoKPP gene to chromosome 1q31-q32 near a dihydropyridine (DHP) receptor gene. This receptor functions as a voltage-gated calcium channel and is also critical for excitation-contraction coupling in a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
